Live Breaking News & Updates on Min000044995

Stay updated with breaking news from Min000044995 . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Trastuzumab Deruxtecan Demonstrates Real-World Intracranial Efficacy in Metastatic HER2+ Breast Cancer

Data from a real-world study in Japan showed that fam-trastuzumab deruxtecan-nxki displayed intracranial efficacy in patients with HER2-positive breast cancer harboring brain metastases and/or leptomeningeal carcinomatosis. ....

Naoki Niikura , Breast Oncology , Tokai University School , Trastuzumab Deruxtecan , Phase 3 Destiny Breast04 Trial , Japans Ministry Of Health , Labor And Welfare , Min000044995 , Brain Metastases And Or Leptomeningeal Carcinomatosis , Her2 Positive Breast Cancer ,